{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:03:34Z","timestamp":1784372614751,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2018RC350002"],"award-info":[{"award-number":["2018RC350002"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["SQ2018YFA090025-04"],"award-info":[{"award-number":["SQ2018YFA090025-04"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.apsb.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T21:54:06Z","timestamp":1611611646000},"page":"1213-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment"],"prefix":"10.1016","volume":"11","author":[{"given":"Junmei","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.01.009_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jbiotec.2010.02.008","article-title":"Whole-body systems approaches for gut microbiota-targeted, preventive healthcare","volume":"149","author":"Zhao","year":"2010","journal-title":"J Biotechnol"},{"key":"10.1016\/j.apsb.2021.01.009_bib2","first-page":"137rv136","article-title":"Therapeutic modulation of microbiota\u2013host metabolic interactions","volume":"4","author":"Holmes","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2021.01.009_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fcimb.2018.00314","article-title":"Effects of metabolites derived from gut microbiota and hosts on pathogens","volume":"8","author":"Li","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2021.01.009_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pharmthera.2015.11.012","article-title":"Gut microbiome in health and disease: linking the microbiome\u2013gut\u2013brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases","volume":"158","author":"Ghaisas","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2021.01.009_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2021.01.009_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut\u2013liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.01.009_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.01.009_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.01.009_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000437034","article-title":"Understanding microbiome data: a primer for clinicians","volume":"33 Suppl 1","author":"Seksik","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.apsb.2021.01.009_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/nu8020078","article-title":"The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility","volume":"8","author":"Ozdal","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2021.01.009_bib11","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.7150\/thno.28068","article-title":"Gut\u2013brain axis metabolic pathway regulates antidepressant efficacy of albiflorin","volume":"8","author":"Zhao","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2021.01.009_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.apsb.2021.01.009_bib13","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41598-019-41894-8","article-title":"Azoreductase activity of dye-decolorizing bacteria isolated from the human gut microbiota","volume":"9","author":"Zahran","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.01.009_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/gut.49.5.656","article-title":"Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide","volume":"46","author":"Lowry","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.01.009_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s13238-010-0090-2","article-title":"Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases","volume":"1","author":"Ryan","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2021.01.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.11.015","article-title":"The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells","volume":"561","author":"Zhang","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2021.01.009_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2013.07.020","article-title":"Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in\u00a0vivo and in\u00a0vitro Parkinson's disease models","volume":"75","author":"Tai","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2021.01.009_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuroscience.2011.11.036","article-title":"FLZ protects dopaminergic neuron through activating protein kinase B\/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models","volume":"202","author":"Bao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2021.01.009_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","article-title":"Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism","volume":"70","author":"Wang","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2021.01.009_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12035-015-9572-9","article-title":"FLZ Attenuates alpha-synuclein-induced neurotoxicity by activating heat shock protein 70","volume":"54","author":"Bao","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2021.01.009_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00210-017-1363-6","article-title":"A novel synthetic derivative of squamosamide FLZ inhibits the high mobility group box 1 protein-mediated neuroinflammatory responses in murine BV2 microglial cells","volume":"390","author":"Li","year":"2017","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.apsb.2021.01.009_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/fcp.12230","article-title":"Targeting CYP51 for drug design by the contributions of molecular modeling","volume":"31","author":"Rabelo","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.01.009_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","article-title":"The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism","volume":"14","author":"Spanogiannopoulos","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2021.01.009_bib24","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s12272-017-0986-y","article-title":"Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs","volume":"40","author":"Noh","year":"2017","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.apsb.2021.01.009_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17512433.2018.1414598","article-title":"The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues","volume":"11","author":"Curro","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.01.009_bib26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.7150\/thno.18290","article-title":"Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2021.01.009_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.chom.2019.02.003","article-title":"Drosophila histone demethylase KDM5 regulates social behavior through immune control and gut microbiota maintenance","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2021.01.009_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.str.2017.05.003","article-title":"An Atlas of beta-glucuronidases in the human intestinal microbiome","volume":"25","author":"Pollet","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2021.01.009_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2012.03.002","article-title":"Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability","volume":"197","author":"Kapetanovic","year":"2012","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2021.01.009_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jcm8010079","article-title":"The impact of cholecystectomy on the gut microbiota: a case-control study","volume":"8","author":"Yoon","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2021.01.009_bib31","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.aad9359","article-title":"Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics","volume":"352","author":"Blanton","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.01.009_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098551","article-title":"Identification of NAD(P)H quinone oxidoreductase activity in azoreductases from P. aeruginosa: azoreductases and NAD(P)H quinone oxidoreductases belong to the same FMN-dependent superfamily of enzymes","volume":"9","author":"Ryan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.01.009_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/DDDT.S48636","article-title":"Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis","volume":"7","author":"Jilani","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.apsb.2021.01.009_bib34","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.bbagen.2013.12.009","article-title":"Identification, modeling and ligand affinity of early deuterostome CYP51s, and functional characterization of recombinant zebrafish sterol 14alpha-demethylase","volume":"1840","author":"Morrison","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2021.01.009_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbapap.2017.10.003","article-title":"In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: special focus on CYP51","volume":"1866","author":"Matowane","year":"2018","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.apsb.2021.01.009_bib36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/molecules22060932","article-title":"In\u00a0vitro study of the metabolic characteristics of eight isoquinoline alkaloids from natural plants in rat gut microbiota","volume":"22","author":"He","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2021.01.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003878","article-title":"Machine learning models and pathway genome data base for trypanosoma cruzi drug discovery","volume":"9","author":"Ekins","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2021.01.009_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/da.22606","article-title":"Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder","volume":"34","author":"Hosang","year":"2017","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.apsb.2021.01.009_bib39","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1021\/ja908995p","article-title":"Enzyme-catalyzed transfer of a ketone group from an S-adenosylmethionine analogue: a tool for the functional analysis of methyltransferases","volume":"132","author":"Lee","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2021.01.009_bib40","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2009.06072.x","article-title":"Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions","volume":"109","author":"Gibrat","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2021.01.009_bib41","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/ecco-jcc\/jjw096","article-title":"Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis","volume":"10","author":"Hern\u00e1ndez-Chirlaquea","year":"2016","journal-title":"J Crohns Colitis"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:46:21Z","timestamp":1761929181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2211383521000125"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.01.009","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}